Camblong Jurgi 4

What Happened
Jurgi Camblong, CEO of SOPHiA GENETICS SA (SOPH), sold 8,500 shares on June 10, 2026 in open‑market transactions, generating approximately $44,501. The reported weighted average price was $5.24 per share; individual trades ranged from $5.13 to $5.42.

Key Details

• Transaction date: June 10, 2026 (Filed on June 11, 2026) — filing appears timely.
• Transaction type/code: Sale (S) — open‑market/private sale listing; executed in multiple transactions.
• Price: Weighted average $5.24; range $5.13–$5.42 (Reporting Person can provide per‑trade breakdown on request).
• Shares sold: 8,500; proceeds ≈ $44,501.
• Shares owned after transaction: Not specified in the provided filing summary.
• Notable footnote: Sale was made pursuant to a prearranged Rule 10b5‑1(c) trading plan (footnote F1). Footnote F2 explains the weighted average and availability of per‑trade prices.

Context
Insider sales executed under a 10b5‑1 plan are preplanned and often routine (e.g., for diversification or liquidity) and do not by themselves indicate a change in the insider’s view of the company. For retail investors, purchases typically carry more interpretive weight than routine sales; this filing documents a small, routine sale by the CEO.